158 related articles for article (PubMed ID: 12428131)
1. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1.
El-Koussy M; Lövblad KO; Steinlin M; Kiefer C; Schroth G
Neuroradiology; 2002 Nov; 44(11):938-41. PubMed ID: 12428131
[TBL] [Abstract][Full Text] [Related]
2. [Early ischemic lesion demonstrated by ictal diffusion-weighted MRI during prior TIA in a patient with cerebral infarction].
Shimizu H; Yoneda Y; Tabuchi M; Yamasaki T; Moriwaki H; Mori E
No To Shinkei; 2002 Mar; 54(3):247-53. PubMed ID: 11968816
[TBL] [Abstract][Full Text] [Related]
3. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report.
Wityk RJ; Hillis A; Beauchamp N; Barker PB; Rigamonti D
Neurosurgery; 2002 Dec; 51(6):1499-505; discussion 1506. PubMed ID: 12445358
[TBL] [Abstract][Full Text] [Related]
4. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
5. Moyamoya disease in a child with neurofibromatosis type-1.
Kwong KL; Wong YC
J Paediatr Child Health; 1999 Feb; 35(1):108-9. PubMed ID: 10234650
[No Abstract] [Full Text] [Related]
6. [Repeated, reversible MR angiographic findings in pediatric moyamoya disease: case report].
Osanai T; Kuroda S; Ishikawa T; Kudo K; Terae S; Isobe M; Iwasaki Y
No Shinkei Geka; 2006 Apr; 34(4):403-7. PubMed ID: 16613222
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance imaging in moyamoya disease].
Fujita K; Shirakuni T; Kojima N; Tamaki N; Matsumoto S
No Shinkei Geka; 1986 Mar; 14(3 Suppl):324-30. PubMed ID: 3703130
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
Rosser TL; Vezina G; Packer RJ
Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
[TBL] [Abstract][Full Text] [Related]
9. Focal time-to-peak changes on perfusion MRI in children with Moyamoya disease: correlation with conventional angiography.
Choi HS; Kim DS; Shim KW; Kim J; Kim ES; Lee SK
Acta Radiol; 2011 Jul; 52(6):675-9. PubMed ID: 21525108
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
11. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
[TBL] [Abstract][Full Text] [Related]
12. [Moyamoya disease in a girl with Down syndrome. Report of one case].
Hernández Ch M; Huete L I; Concha G MJ; Méndez C JI; Sánchez D N; Cuéllar G MC; Retamal R E; Mesa L T
Rev Med Chil; 2009 Aug; 137(8):1066-70. PubMed ID: 19915772
[TBL] [Abstract][Full Text] [Related]
13. Reversible diffusion-weighted lesion in a TIA patient without arterial recanalization: a case report.
Terasawa Y; Iguchi Y; Kimura K; Kobayashi K; Aoki J; Shibazaki K
J Neurol Sci; 2008 Sep; 272(1-2):183-5. PubMed ID: 18558409
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1 association with moyamoya disease.
Koc F; Yerdelen D; Koc Z
Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
[TBL] [Abstract][Full Text] [Related]
15. Alagille syndrome associated with angiographic moyamoya.
Connor SE; Hewes D; Ball C; Jarosz JM
Childs Nerv Syst; 2002 Apr; 18(3-4):186-90. PubMed ID: 11981633
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya syndrome after cranial irradiation for bone marrow transplantation in a patient with acute leukemia.
Ishikawa N; Tajima G; Yofune N; Nishimura S; Kobayashi M
Neuropediatrics; 2006 Dec; 37(6):364-6. PubMed ID: 17357039
[TBL] [Abstract][Full Text] [Related]
17. [Symptomatic arteriovenous fistula in a patient with neurofibromatosis type I].
Anegawa S; Hayashi T; Torigoe R; Iwaisako K; Sakae N; Ogasawara T; Utsunomiya H
No Shinkei Geka; 1997 Apr; 25(4):373-8. PubMed ID: 9125723
[TBL] [Abstract][Full Text] [Related]
18. Role of magnetic resonance perfusion studies in moyamoya disease.
Khanna PC; Lath C; Gadewar SB; Patkar DP
Neurol India; 2004 Jun; 52(2):238-40. PubMed ID: 15269480
[TBL] [Abstract][Full Text] [Related]
19. Beta-thalassemia intermedia associated with moyamoya syndrome.
Göksel BK; Ozdogu H; Yildirim T; Oğuzkurt L; Asma S
J Clin Neurosci; 2010 Jul; 17(7):919-20. PubMed ID: 20399663
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya syndrome associated with systemic lupus erythematosus.
Jeong HC; Kim YJ; Yoon W; Joo SP; Lee SS; Park YW
Lupus; 2008 Jul; 17(7):679-82. PubMed ID: 18625642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
